Cargando…

Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage

BACKGROUND: Persistent infection with oncogenic Human Papillomavirus (HPV) is associated with the development of cervical cancer with each genotype differing in their relative contribution to the prevalence of cervical disease. HPV DNA testing offers improved sensitivity over cytology testing alone...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marongiu, Luigi, Godi, Anna, Parry, John V, Beddows, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053304/ https://www.ncbi.nlm.nih.gov/pubmed/24885011 http://dx.doi.org/10.1186/1471-2407-14-384

Ejemplares similares

Human papillomavirus type 16 long control region and E6 variants stratified by cervical disease stage
por: Marongiu, Luigi, et al.
Publicado: (2014)

Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix(®) or Gardasil(®) Vaccine
por: Godi, Anna, et al.
Publicado: (2015)

Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women
por: Ramanakumar, Agnihotram V, et al.
Publicado: (2010)

Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica
por: Wang, S S, et al.
Publicado: (2003)

Human papillomavirus type 16 and 18 viral loads as predictors associated with abnormal cervical cytology among women in Saudi Arabia
por: Obeid, D.A., et al.
Publicado: (2020)

Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58
por: de Sanjosé, Silvia, et al.
Publicado: (2019)

Detection of high-risk human papillomavirus RNA in urine for cervical cancer screening with HPV 16 & 18/45 genotyping
por: Padhy, Radha Rani, et al.
Publicado: (2020)

Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies
por: Godi, Anna, et al.
Publicado: (2019)

Methylation of the L1 gene and integration of human papillomavirus 16 and 18 in cervical carcinoma and premalignant lesions
por: Torres-Rojas, Francisco Israel, et al.
Publicado: (2018)

Searching for the methylation sites involved in human papillomavirus type 16 and 18‑positive women with cervical cancer
por: Ma, Yanyun, et al.
Publicado: (2022)

Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study
por: Zhang, Donghong, et al.
Publicado: (2010)

Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16
por: Ki, Eun Young, et al.
Publicado: (2016)

Sexual behavior and infection with cervical human papillomavirus types 16 and 18
por: Itarat, Yuwadee, et al.
Publicado: (2019)

Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer
por: Milutin Gašperov, Nina, et al.
Publicado: (2015)

A comprehensive in silico analysis for identification of therapeutic epitopes in HPV16, 18, 31 and 45 oncoproteins
por: Panahi, Heidar Ali, et al.
Publicado: (2018)

Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
por: Huh, Warner K., et al.
Publicado: (2014)

Cross-neutralizing antibodies elicited by the Cervarix(®) human papillomavirus vaccine display a range of Alpha-9 inter-type specificities()
por: Bissett, Sara L., et al.
Publicado: (2014)

Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines
por: Mariz, Filipe Colaço, et al.
Publicado: (2020)

High viral loads of human papillomavirus predict risk of invasive cervical carcinoma
por: Moberg, M, et al.
Publicado: (2005)

Phylogenomic Analysis of Human Papillomavirus Type 31 and Cervical Carcinogenesis: A Study of 2093 Viral Genomes
por: Pinheiro, Maisa, et al.
Publicado: (2021)

Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine
por: Folschweiller, Nicolas, et al.
Publicado: (2019)

Contribution of Surface-Exposed Loops on the HPV16 Capsid to Antigenic Domains Recognized by Vaccine or Natural Infection Induced Neutralizing Antibodies
por: Godi, Anna, et al.
Publicado: (2022)

Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancer
por: de Araújo Catão Zampronha, Rossana, et al.
Publicado: (2013)

Prevalence of Human Papillomavirus subtypes 16 and 18 among Yemeni Patients with Cervical Cancer
por: Ahmed, Hussain Gadelkarim, et al.
Publicado: (2017)

Prognostic significance of human papillomavirus 16 viral load level in patients with oropharyngeal cancer
por: Hashida, Yumiko, et al.
Publicado: (2021)

Multiplex Human Papillomavirus L1L2 virus-like particle antibody binding assay
por: Panwar, Kavita, et al.
Publicado: (2022)

Strategic Significance of Low Viral Load of Human Papillomavirus in Uterine Cervical Cytology Specimens
por: Park, Nora Jee-Young, et al.
Publicado: (2022)

Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins
por: Bissett, Sara L., et al.
Publicado: (2014)

HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology: Data From the Baseline Phase of the Onclarity Trial
por: Stoler, Mark H, et al.
Publicado: (2019)

Viral genome integration of canine papillomavirus 16
por: Luff, Jennifer, et al.
Publicado: (2019)

Development of HPV(16,18,31,45) E5 and E7 peptides-based vaccines predicted by immunoinformatics tools
por: Namvar, Ali, et al.
Publicado: (2020)

Growth Dependence of Human Papillomavirus 16 DNA‐positive Cervical Cancer Cell Lines and Human Papillomavirus 16‐Transformed Human and Rat Cells on the Viral Oncoproteins
por: Watanabe, Sumie, et al.
Publicado: (1993)

The development of simultaneous measurement of viral load and physical status for human papillomavirus 16 and 18 co-infection using multiplex quantitative polymerase chain reaction
por: Prasongdee, Prinya, et al.
Publicado: (2018)

Correlation between multi‐type human papillomavirus infections and viral loads and the cervical pathological grade
por: Li, Yanfang, et al.
Publicado: (2020)

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors
por: Damm, Oliver, et al.
Publicado: (2009)

Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia
por: Baba, Satoshi, et al.
Publicado: (2020)

Genetic Variability and Phylogeny of High Risk HPV Type 16, 18, 31, 33 and 45 L1 Gene in Greek Women
por: Ntova, Chara Kleio, et al.
Publicado: (2011)

Evaluation of Dried Blood Spots and Oral Fluids as Alternatives to Serum for Human Papillomavirus Antibody Surveillance
por: Louie, Karly S., et al.
Publicado: (2018)

Diagnostic value of high‐risk human papillomavirus viral load on cervical lesion assessment and ASCUS triage
por: Wang, Min, et al.
Publicado: (2021)

Correlation between human papillomavirus viral load and cervical lesions classification: A review of current research
por: Zhou, Yilu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8dkqlrsj0oaa363ka3ulb0p9cq